pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,259 catalysts · 4,970 phase readout · 2,346 8k filing · 287 earnings · 274 pdufa · 129 phase 2 completion · 61 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 17 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: approval×type: earnings×type: phase readout×clear all
type
  • phase readout4,970
  • 8k filing2,346
  • earnings287
  • pdufa274
  • phase 2 completion129
  • phase 1 completion61
phase 1 initiation
32
  • phase 1 2 completion28
  • phase 0 trial completion22
  • phase 2 initiation16
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›RECRUITINGphase readoutNCT06004882: Peripheral Nerve Stimulation of Genicular Nerves Versus Conventional Therapy With Intra-articular Steroid Injection for Chronic Knee Pain: A Prospective, Randomized Pilot Study

    Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Peripheral Nerve Stimulation, Genicular Nerves, Chronic Knee Pain

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07543224: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of RSS0393 Ointment in Adult Patients With Plaque Psoriasis.

    Sponsor: Reistone Biopharma Company Limited. Phase: PHASE3. Conditions: Plaque Psoriasis Subjects

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT01386424: Screening for LID Clinical Studies Unit Healthy Volunteer Protocols

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: Zika, Influenza

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01296724: PREMAPIV : Intravesical Pressure Variation at Different Bladder Instillation Volumes in Newborn Children

    Sponsor: Rennes University Hospital. Phase: NA. Conditions: Intensive Care Unit Syndrome

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT04363580: Creation of Auditory Processing Disorder Screening Tool in French

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Auditory Processing Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04232280: Dose-Finding Trial to Evaluate the Safety and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647 in Healthy Adults

    Sponsor: ModernaTX, Inc.. Phase: PHASE2. Conditions: Cytomegalovirus Infection

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07227896: Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants Earlier Within Advanced Parkinson Disease

    Sponsor: AbbVie. Phase: . Conditions: Parkinson's Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07672496: Ulinastatin on Systemic Immune-Inflammation in Patients With Complicated Intra-Abdominal Infection

    Sponsor: Fujian Medical University Union Hospital. Phase: NA. Conditions: Complicated Intra-abdominal Infection (cIAI), Systemic Inflammatory Response, Sepsis, Immune Dysfunction

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07007546: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABSK061 Mini-tablets in Healthy Adult Participants

    Sponsor: Abbisko Therapeutics Co, Ltd. Phase: PHASE1. Conditions: Healthy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06997588: EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)

    Sponsor: Novartis Pharmaceuticals. Phase: PHASE2. Conditions: PIK3CA-related Overgrowth Spectrum (PROS)

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07197788: Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study

    Sponsor: Endogenex, Inc.. Phase: NA. Conditions: Type 2 Diabetes Mellitus, Type2diabetes, Diabetes Mellitus, Type 2, Type 2 Diabetes, Diabetes

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07496203: The Effectiveness of BETY in Knee Osteoarthritis With Intra-Articular Injections

    Sponsor: Hacettepe University. Phase: NA. Conditions: Osteo Arthritis of the Knee, Pain, Pain Management, Exercise

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07598942: Gingival TrxR1 Expression in Periodontal Health and Periodontitis

    Sponsor: Ataturk University. Phase: . Conditions: Periodontitis, Oxidative Stress

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04631042: Developing Brain, Impulsivity and Compulsivity

    Sponsor: National Institute of Mental Health (NIMH). Phase: . Conditions: Typical Development, Obsessive Compulsive Disorder, Conduct Disorder, Attention Deficit Hyperactivity Disorder, Autism Spectrum Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06284642: Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK)

    Sponsor: Second Affiliated Hospital of Nanchang University. Phase: PHASE4. Conditions: Aneurysmal Subarachnoid Hemorrhage

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05711186: Structured Shared Decision Making for Patients Undergoing SAVR or TAVR

    Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: NA. Conditions: Aortic Valve Stenosis, Symptomatic Aortic Stenosis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07104383: VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

    Sponsor: Viking Therapeutics, Inc.. Phase: PHASE3. Conditions: Weight Loss

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06486441: Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)

    Sponsor: Gilead Sciences. Phase: PHASE3. Conditions: Endometrial Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06156254: Community Care Intervention to Decrease COVID-19 Vaccination Inequities

    Sponsor: RAND. Phase: NA. Conditions: COVID-19 Vaccination

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06658405: Clinical Trial Evaluating Secondary HPV Vaccination After Treatment of High-grade Cervical Lesions

    Sponsor: Centre Oscar Lambret. Phase: PHASE2. Conditions: Cervical Lesion

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07597694: Verbal Intent and Gaze Cues on Action Prediction in ASD

    Sponsor: University of Electronic Science and Technology of China. Phase: . Conditions: Autism Spectrum Disorder (ASD), Intellectual Disability

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06747156: A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Refractory Autoimmune Diseases

    Sponsor: Ruijin Hospital. Phase: EARLY_PHASE1. Conditions: Autoimmune Diseases

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06739122: A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

    Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Type 2 Diabetes

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04545151: Verapamil SR in Adults With Type 1 Diabetes

    Sponsor: Medical University of Graz. Phase: PHASE2. Conditions: Diabetes Mellitus, Type 1

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02192151: Study of PHN131 in Healthy Volunteers

    Sponsor: PhytoHealth Corporation. Phase: . Conditions: Analgesia Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06464029: Pathways Mediating Impaired Postural Control in Parkinson's Disease

    Sponsor: University of Minnesota. Phase: . Conditions: Parkinson Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07601529: Comparison of Anterior Sciatic Nerve Block and Adductor Magnus Muscle Plane Block for Anterior Cruciate Ligament Surgery

    Sponsor: Ataturk University. Phase: NA. Conditions: ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06743529: Immediate Versus Substantiated Antibiotic Therapy in Suspected Non-Severe Ventilator-Associated Pneumonia

    Sponsor: Nantes University Hospital. Phase: NA. Conditions: Ventilator-Associated Pneumonia (VAP)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06737731: A Phase I/II Clinical Study of SHR-1681 for Injection in Patients With Advanced Solid Tumors

    Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.. Phase: PHASE1. Conditions: Malignant Solid Tumors

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07451431: Efficacy and Safety of Mirogabalin in Diabetic Peripheral Neuropathic Pain

    Sponsor: Bangladesh Medical University. Phase: PHASE4. Conditions: Diabetic Peripheral Neuropathic Pain (DPNP)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06033131: PI4 - A Trial Assessing Metformin to Prolong Gestation in Preterm Preeclampsia

    Sponsor: Lina Bergman. Phase: PHASE3. Conditions: Preeclampsia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07222202: Evaluation of Flexible Conductive Hearing Aids

    Sponsor: Wake Forest University Health Sciences. Phase: NA. Conditions: Conductive Hearing Loss

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07280637: Regenarative Treatment of Periocular Wrinkles With PDRN

    Sponsor: University of Taubate. Phase: NA. Conditions: Skin Wrinklings

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07145645: Topical Diclofenac vs.Oral Ibuprofen for MSK Pain in Children

    Sponsor: University of Calgary. Phase: PHASE3. Conditions: Musculoskeletal Injury, Pediatrics, Sprain and Strain of Ankle, Sprain Knee, Strain Knee

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07220772: A Study Evaluating Mibavademab Treatment of Obesity Due to Leptin (LEP) Gene Mutations in Children, Adolescents and Adults

    Sponsor: Regeneron Pharmaceuticals. Phase: PHASE3. Conditions: Monogenic Obesity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07146295: Implementation of Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast Cancer

    Sponsor: Isabelle Henskens. Phase: NA. Conditions: Breast Cancer, Sentinel Lymph Node Biopsy (SLNB), Sentinel Lymph Node Detection, Sentinel Lymph Node, Lymphatic Metastasis, Fluorescence Imaging, Indocyanine Green (ICG), Radioisotopes, Lymph Node Mapping

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07668739: Efficacy of Verciguat in TR and RV Failure

    Sponsor: Daejeon St. Mary's hospital. Phase: PHASE4. Conditions: HFrEF, Tricuspid Regurgitation (TR)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07427875: Breathing Exercises for Pain and Anxiety During Arteriovenous Fistula Cannulation

    Sponsor: Emine Kaplan Serin. Phase: NA. Conditions: Hemodialysis, Arteriovenous Fistula Cannulation, Breathing Exercises, Pain, Anxiety, Comfort

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06066957: Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients

    Sponsor: University of Pennsylvania. Phase: PHASE2. Conditions: Cytomegalovirus Infections, Transplant-Related Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07425275: Integrated Oral Care Intervention for Xerostomia in Diabetes Patients

    Sponsor: Khyber Medical University Peshawar. Phase: NA. Conditions: Diabetes Mellitus, Diabetic Neuropathies

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07429357: The REWIRE Behaviour Study

    Sponsor: Gary Goldfield. Phase: NA. Conditions: Anxiety Depression, Social Media

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02650401: Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

    Sponsor: Hoffmann-La Roche. Phase: PHASE1. Conditions: Solid Tumors, CNS Tumors

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07403981: Advocacy, Partnership, Outreach, and Yielding Optimized Care for Oncology Patients

    Sponsor: Stanford University. Phase: NA. Conditions: Colorectal Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05357781: Immunoglobulin Deficiency a Treatable Cause of Fatigue in Patients With Multiple Sclerosis (MS)?

    Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: . Conditions: Hypogammaglobulinemia, Multiple Sclerosis, Fatigue

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06895681: UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations

    Sponsor: University of California, San Francisco. Phase: . Conditions: Solid Tumor, Solid Tumor, Adult, Somatic Mutation, Solid Tumor, Unspecified, Adult, Hereditary Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07396519: Bioequivalence Study of Dronedarone Hydrochloride Tablets

    Sponsor: Shandong New Time Pharmaceutical Co., LTD. Phase: NA. Conditions: Atrial Fibrillation (AF)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04404530: Nutritional Impacts of Palynziq on Patients With Phenylketonuria (PKU)

    Sponsor: Emory University. Phase: . Conditions: Phenylketonurias

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07598630: SHAPE Versus Milligan-Morgan Hemorrhoidectomy for Hemorrhoidal Disease

    Sponsor: Cairo University. Phase: NA. Conditions: Hemorrhoid

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07420530: Respiratory and Real-time Dynamics in Exercise-Induced Paradoxical Vocal Fold Motion

    Sponsor: Indiana University. Phase: EARLY_PHASE1. Conditions: Exercise-Induced Vocal Cord Dysfunction, Paradoxical Vocal Fold Motion, Vocal Cord Dysfunction

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02818465: Role of the Interaction Between Advanced Glycation End Products and Their Receptor RAGE in the Development and the Progression of the Uremic Vasculopathy of Hemodialyzed Patients

    Sponsor: CHU de Reims. Phase: NA. Conditions: Hemodialyzed Patients

    full page →ctgov ↗
    ← prev
    page 83 of 106
    next →